A detailed history of Jpmorgan Chase & CO transactions in Koru Medical Systems, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,553 shares of KRMD stock, worth $6,842. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,553
Previous 14,643 82.57%
Holding current value
$6,842
Previous $34,000 82.35%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$2.06 - $2.99 $24,905 - $36,149
-12,090 Reduced 82.57%
2,553 $6,000
Q1 2024

May 10, 2024

SELL
$2.04 - $2.38 $16,350 - $19,075
-8,015 Reduced 35.37%
14,643 $34,000
Q3 2023

Nov 14, 2023

SELL
$2.37 - $3.52 $12,321 - $18,300
-5,199 Reduced 18.66%
22,658 $61,000
Q2 2023

Aug 11, 2023

BUY
$3.45 - $4.47 $82,541 - $106,944
23,925 Added 608.47%
27,857 $96,000
Q1 2023

May 11, 2023

BUY
$3.55 - $4.23 $13,958 - $16,632
3,932 New
3,932 $16,000

Others Institutions Holding KRMD

About KORU Medical Systems, Inc.


  • Ticker KRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 45,033,100
  • Market Cap $121M
  • Description
  • KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneou...
More about KRMD
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.